Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer
Kim Lucia Schneider(Universitätsmedizin Göttingen), Ramona Schulz‐Heddergott(Universitätsmedizin Göttingen)
Cited by 5
Related Papers
Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer
|Cell Death and Disease|2021|109
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
|Cell Death and Differentiation|2025|9
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1